Cargando…
Identification of Novel CB2 Ligands through Virtual Screening and In Vitro Evaluation
[Image: see text] Cannabinoid receptor type 2 (CB2) is a very promising therapeutic target for a variety of potential indications. However, despite the existence of multiple high affinity CB2 ligands, none have yet been approved as a drug. Therefore, it would be beneficial to explore new chemotypes...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Chemical Society
2023
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930120/ https://www.ncbi.nlm.nih.gov/pubmed/36693026 http://dx.doi.org/10.1021/acs.jcim.2c01503 |